Inhaled corticosteroids and Covid-19: a systematic review and clinical perspective

There is no evidence to support the withdrawal of ICS in patients treated with these drugs, and to do so is likely to be harmful. Patients with asthma and COPD who are stable while using ICS should continue on treatment.

2. Inhaled corticosteroids and Covid19 a systematic review and clinical perspective

.pdf

Download PDF • 360KB